Report of the Working Groups on Breast MRI: Report of the High‐Risk Screening Group

[1]  Matthijs Oudkerk,et al.  First experiences in screening women at high risk for breast cancer with MR imaging , 2000, Breast Cancer Research and Treatment.

[2]  I. Ellis,et al.  Prognostic significance of synchronous and metachronous bilateral breast cancer , 2001, World Journal of Surgery.

[3]  D B Plewes,et al.  Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  N. Weiss,et al.  Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer. , 2001, Journal of the National Cancer Institute.

[5]  A. Hanlon,et al.  Second cancers after conservative surgery and radiation for stages I-II breast cancer: identifying a subset of women at increased risk. , 2001, International journal of radiation oncology, biology, physics.

[6]  D Krebs,et al.  Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. , 2000, Radiology.

[7]  E Grabbe,et al.  Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. , 1999, Radiology.

[8]  J Chang-Claude,et al.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.

[9]  E. Thomson,et al.  Recommendations for follow-up care of individuals with an inherited predisposition to Cancer. II. BRCA1 and BRCA2 , 1997 .

[10]  K Offit,et al.  Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. , 1997, JAMA.

[11]  E. Thomson,et al.  Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium. , 1997, JAMA.

[12]  J Benichou,et al.  Graphs to estimate an individualized risk of breast cancer. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  R. Smith,et al.  The mammography audit: a primer for the mammography quality standards act (MQSA). , 1995, AJR. American journal of roentgenology.

[14]  M. Seller,et al.  Unusual case of Smith-Lemli-Opitz syndrome "type II". , 1995, American journal of medical genetics.

[15]  D. Easton,et al.  Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. , 1995, American journal of human genetics.

[16]  N Risch,et al.  Autosomal dominant inheritance of early‐onset breast cancer. Implications for risk prediction , 1994, Cancer.

[17]  N. Risch,et al.  Autosomal dominant inheritance of early‐onset breast cancer. Implications for risk prediction , 1994 .

[18]  D. Dershaw,et al.  Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  E A Sickles,et al.  Quality assurance. How to audit your own mammography practice. , 1992, Radiologic clinics of North America.